SCM
IDXG

Sio Capital Management’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History

Sio Capital Management’s Portfolio IDXG Stock Details IDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-165,310
Closed -$1.32M – 96
2019
Q1 		$1.32M Buy
+165,310
New +$1.55M 0.36% 59

Other funds holding IDXG

PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
WP
WealthSource Partners San Luis Obispo, California $1.54B AUM 16.68% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Sio Capital Management's IDXG Position: Q2 2019 in Review

Sio Capital Management sold out of Interpace Biosciences, Inc. Common Stock (IDXG) in Q2 2019, closing a stake of 165,310 shares — an estimated $1.32M sold.

Sio Capital Management first reported a position in IDXG in Q1 2019 and held it in 1 quarter. The position peaked at $1.32M in Q1 2019. 18 funds tracked by Wall St. Rank hold IDXG as of Q2 2019.

  • Sio Capital Management reported no remaining Interpace Biosciences, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Sio Capital Management sold 165,310 Interpace Biosciences, Inc. Common Stock shares in Q2 2019, an estimated $1.32M.
  • Sio Capital Management first reported a position in Interpace Biosciences, Inc. Common Stock in Q1 2019 and held it in 1 quarter.
  • Sio Capital Management's Interpace Biosciences, Inc. Common Stock position peaked at $1.32M in Q1 2019.
  • 18 funds tracked by Wall St. Rank held Interpace Biosciences, Inc. Common Stock as of Q2 2019.

Based on Sio Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.